Survival and response after peptide receptor radionuclide therapy with [90Y-DOTA0,Tyr3]octreotide in patients with advanced gastroenteropancreatic neuroendocrine tumors - Valkema, R; Pauwels, S; Kvols, LK (Semin Nucl Med, 2006)
et al.